SCHEDULE: FMR LLC Holds 10.2% Stake in Charles River Labs

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.2% in Charles River Laboratories International, Inc. as of August 31, 2026.

Summary

• FMR LLC and Abigail P. Johnson, through various affiliated entities, collectively beneficially own 4,865,628.13 shares of Charles River Laboratories International, Inc. common stock.
• This ownership stake represents 10.2% of the class of securities.
• The filing is an amendment (Amendment No. 2) to a Schedule 13G.
• The reporting persons have entered into a joint filing agreement.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant but stable institutional ownership stake without immediate strategic shifts.

Positives

• FMR LLC and Abigail P. Johnson maintain a significant, stable ownership position, indicating continued confidence in Charles River Laboratories.
• The reporting persons confirm that the shares were acquired and are held in the ordinary course of business, suggesting a passive investment approach rather than an activist one.

Negatives

• No specific negative financial or operational information is presented in this Schedule 13G filing, as it primarily concerns ownership levels.

Risks

• While not explicitly stated as a risk in this filing, significant institutional ownership can sometimes lead to increased scrutiny or pressure on management regarding performance and strategy.
• The filing does not detail any specific risks associated with the ownership itself, but general market risks for Charles River Laboratories would still apply.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports on beneficial ownership levels.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business..."

Industry Context

StockSavvy.ai notes that a 10.2% ownership stake by a major investment firm like FMR LLC in a company like Charles River Laboratories, a significant player in preclinical CRO services, indicates substantial institutional backing and confidence in the company's long-term prospects within the life sciences sector.

Comparison to Industry Standards

• A 10.2% ownership stake by a single reporting entity is considered a significant institutional holding, often placing the holder among the largest shareholders.
• For a company like Charles River Laboratories, which operates in the competitive contract research organization (CRO) market, such a stake suggests a stable, long-term investment by FMR LLC, aligning with typical investment strategies for large-cap companies in the healthcare and life sciences industries.
• Competitors in the CRO space include companies like Labcorp Drug Development, IQVIA, and WuXi AppTec, where significant institutional ownership is also common, reflecting the capital-intensive nature of the industry.

Stakeholder Impact

• Shareholders: The continued significant ownership by FMR LLC may provide a degree of stability to the stock price and signal confidence to other investors.
• Management: The reporting persons have certified that the shares are not held for the purpose of influencing control, suggesting no immediate pressure for changes in corporate strategy or governance from this specific filing.
• Employees: Stable institutional ownership can contribute to a company's long-term stability, potentially benefiting employees through sustained operations and growth.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to hold their shares in Charles River Laboratories International, Inc.
• Future amendments to this Schedule 13G will be filed if there are material changes in beneficial ownership.

Key Dates

Keywords

Charles River Laboratories, FMR LLC, Abigail P. Johnson, Institutional Ownership, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management